Two studies in the May 2016 issue of the International Forum of Allergy & Rhinology evaluated the different routes of immunotherapy.
Patient Preferences of Immunotherapy Route
In a study out of Cornell University in New York, 228 adults undergoing allergy testing were surveyed regarding their preference of 4 different immunotherapy delivery methods, including subcutaneous (SCIT), sublingual (SLIT), allergy immunotherapy tablets (AIT), and oral mucosal immunotherapy via toothpaste delivery (OMIT).
Subcutaneous immunotherapy was the least preferred, and sublingual immunotherapy was the most preferred.
The participants ranked the following their most preferred:
Patient Compliance with Immunotherapy
A study from Emory University evaluated immunotherapy compliance, comparing SCIT and SLIT. The retrospective analysis of 384 immunotherapy patients (74 SCIT, 200 SLIT) concluded that excellent compliance with SCIT was higher (62%) than SLIT (31%).
Int Forum Allergy Rhinol. 2016;6:454-459.
Int Forum Allergy Rhinol. 2016;6:460-464.
Welcome to Nose and Sinus News on www.higgins-sinus.com, where we post news, highlights, and interesting stories about nose and sinus disease! Check back often!